544 related articles for article (PubMed ID: 9755249)
1. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
2. Semiquantitative and qualitative assessment of hepatic iron in patients with chronic viral hepatitis: relation with grading, staging and haemochromatosis mutations.
Vergani A; Bovo G; Trombini P; Caronni N; Arosio C; Malosio I; Fossati L; Roffi L; Piperno A
Ital J Gastroenterol Hepatol; 1999; 31(5):395-400. PubMed ID: 10470600
[TBL] [Abstract][Full Text] [Related]
3. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
4. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
5. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
[TBL] [Abstract][Full Text] [Related]
6. Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
Sham RL; Ou CY; Cappuccio J; Braggins C; Dunnigan K; Phatak PD
Blood Cells Mol Dis; 1997 Aug; 23(2):314-20. PubMed ID: 9410475
[TBL] [Abstract][Full Text] [Related]
7. Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course.
Corengia C; Galimberti S; Bovo G; Vergani A; Arosio C; Mariani R; Redaelli A; Riva A; Cestari C; Pozzi M; Valsecchi MG; Piperno A
Am J Clin Pathol; 2005 Dec; 124(6):846-53. PubMed ID: 16416733
[TBL] [Abstract][Full Text] [Related]
8. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
9. A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria.
Brissot P; Moirand R; Jouanolle AM; Guyader D; Le Gall JY; Deugnier Y; David V
J Hepatol; 1999 Apr; 30(4):588-93. PubMed ID: 10207799
[TBL] [Abstract][Full Text] [Related]
10. Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions.
Hézode C; Cazeneuve C; Coué O; Roudot-Thoraval F; Lonjon I; Bastie A; Duvoux C; Pawlotsky JM; Zafrani ES; Amselem S; Dhumeaux D
J Hepatol; 1999 Dec; 31(6):979-84. PubMed ID: 10604569
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C, iron status, and disease severity: relationship with HFE mutations.
Tung BY; Emond MJ; Bronner MP; Raaka SD; Cotler SJ; Kowdley KV
Gastroenterology; 2003 Feb; 124(2):318-26. PubMed ID: 12557137
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
13. Hepatic iron overload: direct HFE (HLA-H) mutation analysis vs quantitative iron assays for the diagnosis of hereditary hemochromatosis.
Press RD; Flora K; Gross C; Rabkin JM; Corless CL
Am J Clin Pathol; 1998 May; 109(5):577-84. PubMed ID: 9576576
[TBL] [Abstract][Full Text] [Related]
14. Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosis.
Negro F; Samii K; Rubbia-Brandt L; Quadri R; Male PJ; Zarski JP; Baud M; Giostra E; Beris P; Hadengue A
J Med Virol; 2000 Jan; 60(1):21-7. PubMed ID: 10568758
[TBL] [Abstract][Full Text] [Related]
15. Iron deposition and progression of disease in chronic hepatitis C. Role of interface hepatitis, portal inflammation, and HFE missense mutations.
Pirisi M; Scott CA; Avellini C; Toniutto P; Fabris C; Soardo G; Beltrami CA; Bartoli E
Am J Clin Pathol; 2000 Apr; 113(4):546-54. PubMed ID: 10761457
[TBL] [Abstract][Full Text] [Related]
16. Roles of iron and HFE mutations on severity and response to therapy during retreatment of advanced chronic hepatitis C.
Bonkovsky HL; Naishadham D; Lambrecht RW; Chung RT; Hoefs JC; Nash SR; Rogers TE; Banner BF; Sterling RK; Donovan JA; Fontana RJ; Di Bisceglie AM; Ghany MG; Morishima C;
Gastroenterology; 2006 Nov; 131(5):1440-51. PubMed ID: 17101320
[TBL] [Abstract][Full Text] [Related]
17. Heterozygosity for hereditary hemochromatosis is associated with more fibrosis in chronic hepatitis C.
Smith BC; Gorve J; Guzail MA; Day CP; Daly AK; Burt AD; Bassendine MF
Hepatology; 1998 Jun; 27(6):1695-9. PubMed ID: 9620344
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.
Mah YH; Kao JH; Liu CJ; Chen CL; Chen PJ; Lai MY; Chen DS
Liver Int; 2005 Apr; 25(2):214-9. PubMed ID: 15780041
[TBL] [Abstract][Full Text] [Related]
20. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]